Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1954 2
1960 1
1963 1
1967 1
1974 1
1978 1
1979 2
1980 3
1981 4
1982 5
1983 3
1984 1
1985 1
1989 2
1990 1
1991 3
1994 1
1995 4
1996 3
1997 2
1998 2
1999 7
2000 5
2001 3
2003 5
2004 11
2005 6
2006 7
2007 2
2008 10
2009 7
2010 6
2011 6
2012 6
2013 8
2014 9
2015 13
2016 12
2017 18
2018 11
2019 15
2020 28
2021 21
2022 12
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Interspecies Chimerism with Mammalian Pluripotent Stem Cells.
Wu J, Platero-Luengo A, Sakurai M, Sugawara A, Gil MA, Yamauchi T, Suzuki K, Bogliotti YS, Cuello C, Morales Valencia M, Okumura D, Luo J, Vilariño M, Parrilla I, Soto DA, Martinez CA, Hishida T, Sánchez-Bautista S, Martinez-Martinez ML, Wang H, Nohalez A, Aizawa E, Martinez-Redondo P, Ocampo A, Reddy P, Roca J, Maga EA, Esteban CR, Berggren WT, Nuñez Delicado E, Lajara J, Guillen I, Guillen P, Campistol JM, Martinez EA, Ross PJ, Izpisua Belmonte JC. Wu J, et al. Among authors: ross pj. Cell. 2017 Jan 26;168(3):473-486.e15. doi: 10.1016/j.cell.2016.12.036. Cell. 2017. PMID: 28129541 Free PMC article.
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, Gerolami R, Masi G, Ross PJ, Song T, Bronowicki JP, Ollivier-Hourmand I, Kudo M, Cheng AL, Llovet JM, Finn RS, LeBerre MA, Baumhauer A, Meinhardt G, Han G; RESORCE Investigators. Bruix J, et al. Among authors: ross pj. Lancet. 2017 Jan 7;389(10064):56-66. doi: 10.1016/S0140-6736(16)32453-9. Epub 2016 Dec 6. Lancet. 2017. PMID: 27932229 Clinical Trial.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, Faluyi O, O'Reilly DA, Cunningham D, Wadsley J, Darby S, Meyer T, Gillmore R, Anthoney A, Lind P, Glimelius B, Falk S, Izbicki JR, Middleton GW, Cummins S, Ross PJ, Wasan H, McDonald A, Crosby T, Ma YT, Patel K, Sherriff D, Soomal R, Borg D, Sothi S, Hammel P, Hackert T, Jackson R, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: ross pj. Lancet. 2017 Mar 11;389(10073):1011-1024. doi: 10.1016/S0140-6736(16)32409-6. Epub 2017 Jan 25. Lancet. 2017. PMID: 28129987 Free article. Clinical Trial.
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Barber S, Ryder WD, Ramage J, Davies LM, Bridgewater JA, Valle JW; Advanced Biliary Cancer Working Group. Lamarca A, et al. Among authors: ross pj. Lancet Oncol. 2021 May;22(5):690-701. doi: 10.1016/S1470-2045(21)00027-9. Epub 2021 Mar 30. Lancet Oncol. 2021. PMID: 33798493 Free PMC article. Clinical Trial.
Ten transgenic animal research conferences and counting.
Murray JD, Ross PJ, Van Eenennaam A, Maga EA. Murray JD, et al. Among authors: ross pj. Transgenic Res. 2016 Jun;25(3):271-2. doi: 10.1007/s11248-016-9931-y. Epub 2016 Feb 8. Transgenic Res. 2016. PMID: 26858236 No abstract available.
Developmental competence of porcine genome-edited zygotes.
Gil MA, Martinez CA, Nohalez A, Parrilla I, Roca J, Wu J, Ross PJ, Cuello C, Izpisua JC, Martinez EA. Gil MA, et al. Among authors: ross pj. Mol Reprod Dev. 2017 Sep;84(9):814-821. doi: 10.1002/mrd.22829. Epub 2017 Jun 8. Mol Reprod Dev. 2017. PMID: 28471514 Review.
Livestock Gene Editing by One-step Embryo Manipulation.
Navarro-Serna S, Vilarino M, Park I, Gadea J, Ross PJ. Navarro-Serna S, et al. Among authors: ross pj. J Equine Vet Sci. 2020 Jun;89:103025. doi: 10.1016/j.jevs.2020.103025. Epub 2020 Apr 13. J Equine Vet Sci. 2020. PMID: 32563448 Review.
Livestock pluripotency is finally captured in vitro.
Navarro M, Soto DA, Pinzon CA, Wu J, Ross PJ. Navarro M, et al. Among authors: ross pj. Reprod Fertil Dev. 2019 Jan;32(2):11-39. doi: 10.1071/RD19272. Reprod Fertil Dev. 2019. PMID: 32188555 Review.
265 results